Portfolio
TechAviv's pre-seed founders fund backs and actively supports the world's elite Israeli founders.
.jpg)
Portfolio News
Moderna's Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson's drug
Moderna cofounder Bob Langer and Turing Award winner Yann LeCun have joined the scientific advisory board of Cellular Intelligence, together with Jens Nielsen of the Novo Nordisk Foundation's BioInnovation Institute and Fabian Theis of Helmholtz Munich. CI is building AI models that predict and control how living cells behave, aiming to make new medicines faster and cheaper to develop.
Remepy raises $36 million Series A as it prepares AI-driven Parkinson’s treatment for Phase III
The Israeli company’s Hybridopa program has shown improvements in motor and non-motor symptoms in Phase IIa trials, while a new partnership with Merck is expanding its approach into rare tumors.
Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.'
Bill Ackman invests in AI transitional care co Dimer Health
The company, which is building a new clinical infrastructure designed to close one of healthcare’s most costly and overlooked gaps, the 30 days following hospital discharge, has raised $20 million to date.
Security Startup Torq Raises Cash at $1.2 Billion Valuation
The company builds an AI-native autonomous security operations platform that uses AI agents to automate repetitive and high-volume security tasks such as alert triage, allowing human analysts to focus on complex and high-risk threats. The funding highlights continued strong investor appetite for AI-driven cybersecurity solutions as enterprises struggle with growing attack surfaces and talent shortages in security operations.